| 姓名 | 職稱 | 持有股份 | 代表法人 |
|---|---|---|---|
| Jiang,Hui-Bang | Chairman | 14.17% | |
| Zhang,Xiu-Ji | Director | 0.53% | |
| He,Ji-Rong | Director | 3.58% | GB INVESTMENT CO., LTD. |
| Zheng,Zhi-Quan | Director | 10.33% | |
| Chen,Zheng | Director | 2.26% | Genovate Biotechnology Co., LTD. |
| Gao,Yong-Hao | Independent Director | 0.00% | |
| Chen,Ci-Jian | Independent Director | 0.00% | |
| Jiang,Jie-Rui | Supervisor | 0.59% | |
| Ke,Yue-Mei | Supervisor | 0.00% | |
| Zhang,Xue-Han | Supervisor | 0.56% |
| 項目 | 2024 | 2023 | 2022 |
|---|---|---|---|
| Operating income | 31,478 | 53,738 | 60,109 |
| Operating cost | 18,589 | 51,051 | 47,067 |
| Profit (loss) of initial recognition of biological asset and agricultural products | - | - | - |
| Profit (loss) on changes in fair value less costs to sell of biological asset for current period | - | - | - |
| Operating gross profit (loss) | 12,889 | 2,687 | 13,042 |
| Unrealized profit (loss) on sales of goods | - | - | - |
| Realized profit (loss) on sales of goods | - | - | - |
| Operating gross profit (loss), net | 12,889 | 2,687 | 13,042 |
| Operating expenses | 30,044 | 59,798 | 61,910 |
| Other gain (loss), net | - | - | - |
| Operating profit (loss) | -17,155 | -57,111 | -48,868 |
| Non-operating income and expenses | 3,912 | 388 | 5,180 |
| Net profit (loss) before tax | -13,243 | -56,723 | -43,688 |
| Income tax expense (benefits) | 0 | 0 | 0 |
| Net profit (loss) of ongoing business for the current period | -13,243 | -56,723 | -43,688 |
| Profit (loss) of closed units | - | - | - |
| Profit (loss) of non-jointly controlled equity before merger | - | - | - |
| Net profit (loss) for the current period | -13,243 | -56,723 | -43,688 |
| Other comprehensive profit (loss), net | - | - | - |
| Comprehensive net profit and loss of non-jointly controlled equity before merger | - | - | - |
| Total comprehensive profit and loss for the current period | -13,243 | -56,723 | -43,688 |
| Net profit (loss) attributable to owners of parent company | - | - | - |
| Net profit (loss) form equity attributable to former owner of business combination under common control | - | - | - |
| Net profit (loss) attributable to non-controlling interests | - | - | - |
| Comprehensive profit (loss) attributable to owners of parent company | - | - | - |
| Comprehensive profit (loss) form equity attributable to former owner of business combination under common control | - | - | - |
| Comprehensive profit (loss) attributable to non-controlling interests | - | - | - |
| Basic earnings per share (yuan) | 0 | -1 | -1 |
| 項目 | 2024 | 2023 | 2022 |
|---|---|---|---|
| Net cash inflow (outflow) from operating activities | - | - | - |
| Net cash inflows (outflows) from investing activities | - | - | - |
| Net cash inflow (outflow) from financing activities | - | - | - |
| Effect of Exchange Rate Changes on Cash and Cash Equivalents | - | - | - |
| Increase (decrease) in cash and cash equivalents in the current period | - | - | - |
| Beginning balance of cash and cash equivalents | - | - | - |
| Ending balance of cash and cash equivalents | - | - | - |
| 項目 | 2024 | 2023 | 2022 |
|---|---|---|---|
| Current asset | 166,887 | 182,992 | 111,579 |
| Non-current asset | 267,324 | 214,378 | 191,540 |
| Total asset | 434,211 | 397,370 | 303,119 |
| Current liability | 124,102 | 83,498 | 31,789 |
| Non-current liability | 12,619 | 3,139 | 3,874 |
| Total liability | 136,721 | 86,637 | 35,663 |
| share capital | 498,000 | 498,000 | 398,000 |
| Equity - secruity token | - | - | - |
| capital reserve | - | - | - |
| retained earning | -200,510 | -187,267 | -130,544 |
| Other equity | - | - | - |
| Treasury stock | - | - | - |
| Total equity attributable to owners of parent company | - | - | - |
| Equity attributable to former owner of business combination under common control | - | - | - |
| Equity attributable to non-controlling interest before business merger under common control | - | - | - |
| Non-controlling interests | - | - | - |
| Total Equity | 297,490 | 310,733 | 267,456 |
| Share capital awaiting retirement (unit: share) | - | - | - |
| Issued shares of advance equity (unit: shares) | 0 | 0 | 0 |
| Treasury shares of the parent company held by the parent company and its subsidiaries (unit: share) | 0 | 0 | 0 |
| Net asset value per share | 5 | 6 | 6 |
